Hepatitis C knowledge among staff in U.S. drug treatment programs

Area of Science:

• Addiction Medicine
• Infectious Diseases
• Public Health

Background:

• Staff in drug treatment programs are crucial for addressing patients' hepatitis C virus (HCV) needs.
• Effective patient support necessitates accurate HCV knowledge among program staff.
• Gaps in staff knowledge can impede comprehensive patient care.

Purpose of the Study:

• To assess the current level of hepatitis C virus (HCV) knowledge among staff in various drug treatment settings.
• To identify specific areas where HCV knowledge is lacking among healthcare professionals in these programs.
• To determine if staff credentials or program type correlate with HCV knowledge levels.

Main Methods:

• A cross-sectional study involving 104 staff members from two drug-free and two methadone maintenance treatment programs (MMTPs) in the New York metropolitan area.
• Administration of a 20-item Hepatitis C Virus (HCV) Knowledge Assessment to evaluate understanding of the virus.
• Analysis of assessment scores stratified by staff credentials (medically credentialed vs. non-medically credentialed) and program type (MMTP vs. drug-free).

Main Results:

• A significant proportion of staff (5 out of 20 items) demonstrated inadequate knowledge regarding hepatitis C virus (HCV).
• Average knowledge assessment scores varied considerably: 70% for medically credentialed staff, 71% for non-medically credentialed staff in MMTPs, and 45% for non-medically credentialed staff in drug-free programs.
• A majority of non-medically credentialed staff in drug-free programs reported no prior HCV-specific training.

Conclusions:

• Substantial gaps in hepatitis C virus (HCV) knowledge exist among staff in drug treatment programs, particularly in drug-free settings.
• The findings underscore a critical need for comprehensive and targeted HCV education and training for all personnel involved in drug treatment.
• Implementing effective HCV training programs is essential to enhance staff capacity in supporting patients with HCV-related needs.